Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department: Randomised, Double Blind Clinical Trial

NCT03238391 is registered in ClinicalTrials.gov with Derince Training and Research Hospital as lead sponsor.

NCT NCT03238391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department: Randomised, Double Blind Clinical Trial
Lead sponsor
Derince Training and Research Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 15, 2017
Completion date
February 15, 2018
Enrollment
350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy